Unexpected SARS-CoV-2 cardiorespiratory arrest in a myopathy patient undergoing immunosuppressive treatment: A case report

RATIONALE: It is recommended that patients with Rheumatic diseases that are at high risk of developing active infections be screened for Tuberculosis, Hepatitis B, and Hepatitis C before receiving second-line immunosuppressive therapies. With the emergence 2019 novel coronavirus (SARS-CoV-2), expand...

Descripción completa

Detalles Bibliográficos
Autores principales: DePace, Nicholas L., Soloway, Stephen, Roshal, David, Soloway, Alyxandra Morgan, Colombo, Joe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386952/
https://www.ncbi.nlm.nih.gov/pubmed/32791748
http://dx.doi.org/10.1097/MD.0000000000021377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386952/
https://www.ncbi.nlm.nih.gov/pubmed/32791748
http://dx.doi.org/10.1097/MD.0000000000021377

Ejemplares similares